These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 718122)

  • 1. [Effects of long-term 1alpha-(OH) D3 therapy on the hyperparathyroidism of children on maintenance hemodialysis (proceedings) (author's transl)].
    Balsan S; Lévy D; Guéris J; Garabédian M; Broyer M
    Ann Endocrinol (Paris); 1978; 39(3):221-2. PubMed ID: 718122
    [No Abstract]   [Full Text] [Related]  

  • 2. Administration of calcium carbonate with adequate doses of vitamin D metabolite to patients on hemodialysis improves mild secondary hyperparathyroidism.
    Okada K; Takahashi S; Hatano M
    Nihon Jinzo Gakkai Shi; 1990 Aug; 32(8):899-903. PubMed ID: 2250406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dialysis bone disease in children. Six cases (author's transl)].
    Luciani JC; Ferran JL; Dumas ML; Meunier P; Dumas R
    Nouv Presse Med; 1977 Nov; 6(39):3616-9. PubMed ID: 607175
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of risk factors on secondary hyperparathyroidism undergoing long-term haemodialysis with vitamin D3.
    Mizumoto D; Watanabe Y; Fukuzawa Y; Yuzawa Y; Yamazaki C
    Nephrol Dial Transplant; 1994; 9(12):1751-8. PubMed ID: 7708259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparisons between oral pulse alfacalcidol therapy and daily therapy in maintenance hemodialysis patients with secondary hyperparathyroidism: a randomized, controlled, and multicenter study.
    Gu Y; Ding F; Chen N; Mei CL; Qian JQ; Wang XY; Shi W; Hou FF; Li XW; Wang M; Chen YP
    Ren Fail; 2005; 27(2):205-12. PubMed ID: 15807187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled trial of falecalcitriol versus alfacalcidol in suppression of parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.
    Akiba T; Marumo F; Owada A; Kurihara S; Inoue A; Chida Y; Ando R; Shinoda T; Ishida Y; Ohashi Y
    Am J Kidney Dis; 1998 Aug; 32(2):238-46. PubMed ID: 9708607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effect of 1alpha-hydroxycholecalciferol on the abnormal calcium metabolism in hemodialysis patients.--Studies on patients showing low serum calcium and high alkaline phosphatase (author's transl)].
    Asai K; Ohkura T; Sakamoto N; Kawahara H; Yamazaki C
    Nihon Jinzo Gakkai Shi; 1978 Sep; 20(9):967-77. PubMed ID: 713173
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapeutic application of vitamin D, its derivatives and analogues (author's transl)].
    Balsan S
    Ann Endocrinol (Paris); 1981; 42(4-5):492-6. PubMed ID: 6896128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of severe secondary hyperparathyroidism in dialysis patients by intravenous 1 alpha(OH) vitamin D3, oral CaCO3 and low dialysate calcium.
    Moriniere P; el Esper N; Viron B; Judith D; Bourgeon B; Farquet C; Gheerbrant J; Chapuy M; Van Orshoven A; Pamphile R
    Kidney Int Suppl; 1993 Jun; 41():S121-4. PubMed ID: 8320904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoparathyroidism: practice and theoretical backgrounds for 1 alpha(OH)D3 treatment.
    Ogata E
    Bone Miner; 1990 Jun; 9(3):229-32. PubMed ID: 2364181
    [No Abstract]   [Full Text] [Related]  

  • 12. 1-Alpha-hydroxy vitamin D3 in primary hyperparathyroidism.
    Boyle IT; Fogelman I; Beastall GH; Joffe S; Boyce B
    Br Med J; 1979 Mar; 1(6166):822-3. PubMed ID: 435823
    [No Abstract]   [Full Text] [Related]  

  • 13. 1-alpha-Hydroxyvitamin D3 in the management of primary hyperparathyroidism with bone disease.
    Boyle IT; Hodsman ID; Allam BF; Boyce B; McLennan I
    Calcif Tissue Res; 1977 May; 22 Suppl():415. PubMed ID: 912560
    [No Abstract]   [Full Text] [Related]  

  • 14. Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis.
    Fukagawa M; Okazaki R; Takano K; Kaname S; Ogata E; Kitaoka M; Harada S; Sekine N; Matsumoto T; Kurokawa K
    N Engl J Med; 1990 Aug; 323(6):421-2. PubMed ID: 2370898
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of alphacalcidole on selected markers of the bone turnover in hemodialysed patients with secondary hyperparathyroidism].
    Nowak Z; Wierzbicki P; Konieczna M; Wańkowicz Z
    Pol Merkur Lekarski; 1998 Nov; 5(29):288-91. PubMed ID: 10101503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of pulse therapy using 1 alpha(OH)D on secondary hyperparathyroidism in patients on maintenance hemodialysis].
    Yoshida K; Hirayama A; Tanaka N; Yasukawa M; Saka M; Kaneko Y; Maruyama Y; Motomiya Y; Ozono S; Hirao Y
    Nihon Jinzo Gakkai Shi; 1990 Oct; 32(10):1117-23. PubMed ID: 2287104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medical problems of longterm dialysis (author's transl)].
    Dobbelstein H
    MMW Munch Med Wochenschr; 1975 May; 117(20):861-4. PubMed ID: 806001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does long-term calcitriol therapy in dialyzed patients turn 'hyperparathyroid' into 'osteomalacic' problem?
    Giachino G; Jeantet A; Piccoli G
    Nephron; 1985; 40(1):124-5. PubMed ID: 3839049
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacological parathyroidectomy by oral 1,25(OH)2D3 pulse therapy.
    Tsukamoto Y; Nomura M; Marumo F
    Nephron; 1989; 51(1):130-1. PubMed ID: 2915748
    [No Abstract]   [Full Text] [Related]  

  • 20. [Osteopathy and serum parathormone and 25-hydroxycholecalciferol levels in patients on long-term haemodialysis (author's transl)].
    Zazgornik J; Kokot F; Pietrek J; Schmidt P; Kopsa H
    Wien Klin Wochenschr; 1978 Jul; 90(14):496-9. PubMed ID: 676306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.